|
Astrocytomas
|
|
|
|
Mathieu NT, Genet D, Labrousse F, Bouillet P, Denes
SL, Martin J, Labourey JL, Venat L, Clavere P, Moreau JJ
Pre-irradiation chemotherapy for newly diagnosed
high grade astrocytoma
Anticancer Res. 2004 Mar-Apr;24(2C):1249-53.
|
|
|
Atypical
teratoid/rhabdoid t.
|
|
|
|
|
Gidwani P, Levy A, Goodrich J, Weidenheim K,
Kolb EA.
Successful outcome with tandem myeloablative chemotherapy and autologous
peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid
tumor of the central nervous system
J Neurooncol.
2008 Jun;88(2):211-5.
Epub 2008 Mar 04
Abstract | 
Links | 
Issue
|
|
|
Brain
Tumors
|
|
|
|
|
Drappatz
J, Schiff D, Kesari S, Norden AD, Wen PY.
Medical management of brain tumor patients.
Neurol Clin.
2007 Nov;25(4):1035-71.
Abstract
|
|
|
Weller M
Chemotherapy for brain tumors in adult patients
Nervenarzt. 2008 Feb 6; 79(2):231-41
Abstract |
Links | BL 7:4
|
|
|
Choroid
Plexus Tumors
|
|
|
|
|
Wrede B, Liu P, Wolff JE
Chemotherapy improves the survival of patients with choroid plexus
carcinoma: a meta-analysis of individual cases with choroid plexus tumors
J Neurooncol.
2007 Dec;85(3):345-51.
Epub 2007 Jun 19
Abstract |
 Reprint |
Links | BL 7:6
|
|
|
Glioblastoma
|
|
|
|
|
Colman H, Aldape K
Molecular predictors in glioblastoma: toward personalized therapy
Arch Neurol.
2008 Jul;65(7):877-83
Abstract |
Links |
BL 7:15
|
|
|
Debinski
W
Drug cocktails for effective treatment of glioblastoma multiforme
Expert Rev Neurother. 2008 Apr;8(4):515-7
Abstract |
 Full Text |
Reprint |
Links | BL 7:9
|
|
|
Fadul CE, Wen PY, Kim L, Olson JJ.
Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma
multiforme
J Neurooncol.
2008 Sep;89(3):339-57.
Epub 2008 Aug 20
Abstract |
Links | BL 7:17
|
|
Hau
P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer
O, Wismeth C, Klinkhammer-Schalke M, Allgauer M, Schuierer G, Koch H,
Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A
Salvage
therapy in patients with glioblastoma: is there any benefit?
Cancer. 2003 Dec 15;98(12):2678-86.
|
|
|
Minniti
G, Muni R, Lanzetta G, Marchetti P, Enrici RM.
Chemotherapy for glioblastoma: current treatment and future perspectives for
cytotoxic and targeted agents
Anticancer Res. 2009 Dec 1;29(12):5171-84
Abstract |
Links |
CNO 9(2)
|
|
|
Sathornsumetee
S, Rich JN.
Designer therapies for glioblastoma multiforme
Ann N Y Acad Sci. 2008 Oct;1142:108-32. Published Online: 23 Oct 2008
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Wen PY
New developments in targeted molecular therapies for glioblastoma
Expert Rev Anticancer Ther. 2009 Jan;9(1):7-10
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Gliomas
(High-Grade)
|
|
|
|
|
Anderson E, Grant R, Lewis SC, Whittle IR
Randomized Phase III controlled trials of therapy in malignant glioma:
where are we after 40 years?
Br J
Neurosurg. 2008 Jun;22(3):339-49
Abstract |
Links |
BL 7:14
|
|
Levin VA
Chemotherapy for
brain tumors of astrocytic and oligodendroglial lineage: the past decade and
where we are heading
Neuro-oncol. 1999 Jan;1(1):69-80
|
|
Satoshi
Nakasu, Tadateru Fukami, Kazumi Baba, Masayuki Matsuda
Immunohistochemical
study for O6-methylguanine-DNA methyltransferase in the
non-neoplastic and neoplastic components of gliomas
Journal
of Neuro-Oncology, 70(3):
333-340, December 2004. (Abstract+)
|
|
|
Perry J, Laperriere N, Zuraw L, Chambers A,
Spithoff K, Cairncross JG
Adjuvant chemotherapy for adults with malignant glioma: a systematic
review
Can J Neurol Sci. 2007 Nov;34(4):402-10
Abstract |
Links | BL 7:1
|
|
Stewart LA
Chemotherapy in adult high-grade glioma: a
systematic review and meta-analysis of individual patient data from 12
randomised trials
Lancet. 2002 Mar 23;359(9311):1011-8.
|
|
R.
Stupp
Current
status of malignant glioma chemotherapy - hype or hope?
ECCO 12 - the European Cancer
Conference. Copenhagen, Denmark, 21-25 September 2003.
Abstract No. 82
European Journal of Cancer Supplements; Vol. 1, No. 5, September 2003, page
S28
|
|
|
Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD,
Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM
Intensive chemotherapy improves survival in pediatric high-grade glioma
after gross total resection: results of the HIT-GBM-C protocol
Cancer. 2009 Dec
2. [Epub ahead of print]
Abstract |
Links |
CNO 9(1)
|
|
|
Hemangiopericytoma
|
|
|
|
|
Chamberlain MC, Glantz MJ
Sequential salvage chemotherapy for recurrent intracranial
hemangiopericytoma
Neurosurgery. 2008 Oct;63(4):720-6; author reply 726-7
Abstract |
Links |
Issue
|
|
|
Medulloblastoma
|
|
|
|
|
Gajjar A
High-dose chemotherapy for recurrent medulloblastoma: time for a
reappraisal
Cancer. 2008 Feb 27; [Epub
ahead of print]
Abstract |
Links | BL 7:6
|
|
|
Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero
CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan
P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza
C, Polastri D, Ravagnani F, Fossati-Bellani F
No
Salvage Using High-Dose Chemotherapy Plus/Minus Reirradiation for Relapsing
Previously Irradiated Medulloblastoma
Int
J Radiat Oncol Biol Phys. 2008 Nov 17. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Metastatic
Tumors
|
|
|
|
|
Cavaliere
R, Schiff D.
Chemotherapy and cerebral metastases: misperception or reality?
Neurosurg Focus.
2007 Mar 15;22(3):E6.
PMID:
17608359 [PubMed - in process]
|
|
|
Mehta
MP, Paleologos NA, Mikkelsen T, Robinson PD, Ammirati M, Andrews DW, Asher
AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS,
McDermott M, Olson JJ, Patchell RA, Ryken TC, Kalkanis SN
The role of chemotherapy in the management of newly diagnosed brain
metastases: a systematic review and evidence-based clinical practice
guideline
J Neurooncol.
2009 Dec 4. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Links |
CNO 9(1)
|
|
|
Oligodendroglial
Tumors
|
|
|
|
JG Cairncross, K Ueki, MC Zlatescu, DK
Lisle, DM Finkelstein, RR Hammond, JS Silver, PC Stark, DR Macdonald, Y Ino,
DA Ramsay and DN Louis
Specific genetic predictors
of chemotherapeutic response and survival in patients with anaplastic
oligodendrogliomas
Journal Of The National Cancer Institute, Vol 90, 1473-1479; 7 October 1998.
(PDF Full Text)
|
|
|
Sunyach MP, Jouvet A, Perol D, Jouanneau E,
Guyotat J, Gignoux L, Carrie C, Frappaz D
Role of exclusive chemotherapy as first line treatment in
oligodendroglioma
J Neurooncol.
2007 Dec;85(3):319-28.
Epub 2007 Jun 14
Abstract |
Reprint |
Links | BL 7:6
|
|
|
Rhabdomyosarcoma
|
|
|
|
M. Stevens, A. Rey, N. Bouvet,
C. Ellershaw, J. Sanchez de Toledo, O. Oberlin
SIOP MMT 95: Intensified (6 drug) versus standard
(IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8515
|
|
|
Tumors
|
|
|
|
|
Silvio Garattini, Vittorio Bertele'
Efficacy, safety, and cost of new
anticancer drugs
BMJ 2002;325:269-271 ( 3 August )
Abstract |
Full Text |
Reprint |
Links | BL
1:2
|
|
